fa 45 24 11 (Eppendorf AG)
Eppendorf AG is a verified supplier 
96
Structured Review
Eppendorf AG
fa 45 24 11
Fa 45 24 11, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 96/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotor+fa+45+24+11/Rotor+FA-45-24-11/10__3390_slash_vetsci13100997-82-28-31
Average 96 stars, based on 164 article reviews
Fa 45 24 11, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 96/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotor+fa+45+24+11/Rotor+FA-45-24-11/10__3390_slash_vetsci13100997-82-28-31
Average 96 stars, based on 164 article reviews
fa 45 24 11 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Centrifugation:Article Title: There is an “I” in team: individual improvements in supercharged cellulase cocktail facilitates cooperative cellulose degradation Article Snippet: Cells were lysed via sonication with a Qsonica Q700 sonicator with 1/8′′ microtip probe for 1 min (Amplitude = 20, pulse on time: 5 s, pulse off time: 30 s) on ice to avoid overheating. .. Soluble cell lysates were clarified from insoluble cell debris by centrifugation at 15,500 × g for 45 min in an Eppendorf 5424 centrifuge with Article Title: There is an "I" in team: individual improvements in supercharged cellulase cocktail facilitates cooperative cellulose degradation. Article Snippet: Cells were lysed via sonication with a Qsonica Q700 sonicator with 1/8” microtip probe for 1 minute (Amplitude = 20, pulse on time: 5 s, pulse off time: 30 s) on ice to avoid overheating. .. Soluble cell lysates were clarified from insoluble cell debris by centrifugation at 15,500 x g for 45 minutes in an Eppendorf 5424 centrifuge with Article Title: Comparative biophysical and functional analysis of TCZ-UFRJ, a potential biosimilar to Actemra. Article Snippet: Biosimilar antibodies have become increasingly significant in the pharmaceutical market, driven by the expiration of patents on many reference products.. This study presents a comparative analysis between the originator tocilizumab, used to treat inflammatory diseases such as rheumatoid arthritis, and the biosimilar candidate TCZ-UFRJ, produced in HEK293 cells.. The investigation focused on various aspects, including primary, secondary, and tertiary structures, intact mass analysis, glycosylation pattern, and functional testing using the IL-6-sensitive THP-1 cell line and ligand binding assay. Article Title: There is an “I” in team: individual improvements in supercharged cellulase cocktail facilitates cooperative cellulose degradation Article Snippet: Cells were lysed via sonication with a Qsonica Q700 sonicator with 1/8” microtip probe for 1 minute (Amplitude = 20, pulse on time: 5 s, pulse off time: 30 s) on ice to avoid overheating. .. Soluble cell lysates were clarified from insoluble cell debris by centrifugation at 15,500 x g for 45 minutes in an Eppendorf 5424 centrifuge with Incubation:Article Title: The −10 region adjacent to open reading frames is a common expression pattern in Deinococcus-Thermus Article Snippet: .. The mixture was incubated on ice for 30 min, followed by the addition of 900 μl of TGY culture medium and further incubation at 30°C with shaking at 200 rpm (Stab S2 Stackable Incubator Shaker, Radobio Scientific Co., Ltd.) for 6 h. After incubation, the cells were centrifuged at 8,000 rpm (Centrifuge Article Title: Comparative biophysical and functional analysis of TCZ-UFRJ, a potential biosimilar to Actemra. Article Snippet: Biosimilar antibodies have become increasingly significant in the pharmaceutical market, driven by the expiration of patents on many reference products.. This study presents a comparative analysis between the originator tocilizumab, used to treat inflammatory diseases such as rheumatoid arthritis, and the biosimilar candidate TCZ-UFRJ, produced in HEK293 cells.. The investigation focused on various aspects, including primary, secondary, and tertiary structures, intact mass analysis, glycosylation pattern, and functional testing using the IL-6-sensitive THP-1 cell line and ligand binding assay. Purification:Article Title: Comparative biophysical and functional analysis of TCZ-UFRJ, a potential biosimilar to Actemra. Article Snippet: Biosimilar antibodies have become increasingly significant in the pharmaceutical market, driven by the expiration of patents on many reference products.. This study presents a comparative analysis between the originator tocilizumab, used to treat inflammatory diseases such as rheumatoid arthritis, and the biosimilar candidate TCZ-UFRJ, produced in HEK293 cells.. The investigation focused on various aspects, including primary, secondary, and tertiary structures, intact mass analysis, glycosylation pattern, and functional testing using the IL-6-sensitive THP-1 cell line and ligand binding assay. Extraction:Article Title: Comparative biophysical and functional analysis of TCZ-UFRJ, a potential biosimilar to Actemra. Article Snippet: Biosimilar antibodies have become increasingly significant in the pharmaceutical market, driven by the expiration of patents on many reference products.. This study presents a comparative analysis between the originator tocilizumab, used to treat inflammatory diseases such as rheumatoid arthritis, and the biosimilar candidate TCZ-UFRJ, produced in HEK293 cells.. The investigation focused on various aspects, including primary, secondary, and tertiary structures, intact mass analysis, glycosylation pattern, and functional testing using the IL-6-sensitive THP-1 cell line and ligand binding assay. Transferring:Article Title: Comparative biophysical and functional analysis of TCZ-UFRJ, a potential biosimilar to Actemra. Article Snippet: Biosimilar antibodies have become increasingly significant in the pharmaceutical market, driven by the expiration of patents on many reference products.. This study presents a comparative analysis between the originator tocilizumab, used to treat inflammatory diseases such as rheumatoid arthritis, and the biosimilar candidate TCZ-UFRJ, produced in HEK293 cells.. The investigation focused on various aspects, including primary, secondary, and tertiary structures, intact mass analysis, glycosylation pattern, and functional testing using the IL-6-sensitive THP-1 cell line and ligand binding assay. |